Decitabine, Cedazuridine

• A study to evaluate the safety and efficacy of oral decitabine plus ivosidenib in newly diagnosed adult patients with acute myeloid leukemia… Pending
  2025-523238-17-00 Phase II 1 country Fundacion PETHEMA
• A Study of Tolinapant in Combination with Oral Decitabine/Cedazuridine and Oral Decitabine/Cedazuridine Alone in Subjects with R/R PTCL Recruiting
  2022-500391-62-00 Phase I/II 5 countries Taiho Oncology Inc.
• A randomized, run-in, phase II study of nivolumab combined with ipilimumab and oral decitabine/cedazuridine (ASTX727) or nivolumab combined … Recruiting
  2024-518891-29-00 Phase II 1 country Fondazione NIBIT Onlus
• PHASE II STUDY OF AZACITIDINE IN COMBINATION WITH LOW DOSE INTENSITY VENETOCLAX IN PATIENTS WITH ACUTE MYELOID LEUKEMIA WITH INTEGRATION OF … Recruiting
  2023-510415-19-00 Phase II 4 countries Rigshospitalet
• A Study of the Pharmacokinetics, Safety, and Efficacy of ASTX727 in Combination with Venetoclax in AML Ended
  2024-516294-78-00 Phase II 1 country Taiho Oncology Inc.
• Extension Study for Subjects Who Participated in Prior Clinical Studies of ASTX727 Ended
  2024-516293-29-01 Phase II 8 countries Taiho Oncology Inc.
• A Randomized, Open-Label, Phase 1-2 Study of ASTX727 Low Dose (ASTX727 LD) Extended Schedule in Subjects with Lower Risk (IPSS Low or Interm… Ended
  2024-516296-32-00 Phase I (Other) 3 countries Taiho Oncology Inc.
• ASTX727 AND DONOR LYMPHOCYTE INFUSIONS AFTER ALLOGENEIC STEM CELL TRANSPLANTATION IN VERY HIGH RISK MDS OR AML PATIENTS Ended
  2024-515353-24-00 Phase II 1 country Groupe Francophone Des Myelodysplasies

Showing 1–8 of 8 trials